Nasrin B Ansari from Princeton, NJ, age 67

Resumes

Nasrin Ansari

view source

Us Patents

6-Substituted 2-(Benzimidazolyl)Purine And Purinone Derivatives For Immunosuppression
view source
US Patent:

7919490, Apr 5, 2011
Filed:

Oct 4, 2007
Appl. No.:

11/867562
Inventors:

Irina Neagu - Plainsboro NJ, US
David Diller - East Windsor NJ, US
Celia Kingsbury - Cream Ridge NJ, US
Adolph C. Bohnstedt - Burlington NJ, US
Michael J. Ohlmeyer - Plainsboro NJ, US
Vidyadhar Paradkar - Sommerville NJ, US
Nasrin Ansari - Monmouth Junction NJ, US
Assignee:

Wyeth LLC - Madison NJ
International Classification:

C07D 473/32
C07D 473/18
A61K 31/52
A61K 31/522
A61P 37/06
A61P 11/06
A61P 35/02
C07D 239/48
C07D 239/50
C07D 405/12
C07D 405/14
US Classification:

5142285, 5142342, 51421115, 51421706, 51425216, 5142632, 51426321, 51426322, 51426324, 540575, 540600, 544 61, 544 81, 544276, 544277, 544321, 544323, 544324, 544326, 544328, 544332, 549396, 549399, 549404
Abstract:

The present invention provides novel purinones and purines useful for the prevention and treatment of autoimmune diseases, inflammatory disease, mast cell mediated disease and transplant rejection. The compounds are of the general formulae I and II shown below, in which Q is selected from the group consisting of CX and nitrogen; and A is chosen from the group consisting of H, (C-C) alkyl, heteroaryl, and aryl:.

5-Phenyl-Isoxazole-3-Carboxamide Derivatives As Trpv1 Modulators
view source
US Patent:

8211927, Jul 3, 2012
Filed:

Jul 31, 2008
Appl. No.:

12/671113
Inventors:

Andrew Laird Roughton - Toronto, CA
Michael Ohlmeyer - Plainsboro NJ, US
Irina Neagu - Belmont MA, US
Steven G. Kultgen - Salt Lake City UT, US
Nasrin Ansari - Monmouth Junction NJ, US
Yajing Rong - Yardley PA, US
Paul David Ratcliffe - Newhouse, GB
Ronald Palin - Newhouse, GB
Assignee:

MSD, Oss B.V. - Oss
International Classification:

A61K 31/42
C07D 261/18
US Classification:

514378, 548248
Abstract:

The present invention relates to isoxazole-3-carboxamide derivative having the general Formula (I), or a pharmaceutically acceptable salt thereof, to pharmaceutical compositions comprising the same, as well as to the use of said isoxazole-3-carboxamide derivatives for the treatment of TRPV1 mediated disorders, such as acute and chronic pain disorders, acute and chronic neuropathic pain, acute and chronic inflammatory pain, respiratory diseases, and lower urinary tract disorders.

N-Benzyl,N'-Arylcarbonylpiperazine Derivatives
view source
US Patent:

8314091, Nov 20, 2012
Filed:

Aug 19, 2008
Appl. No.:

12/194146
Inventors:

Andrew Laird Roughton - Plainsboro NJ, US
Irina Neagu - Plainsboro NJ, US
Jui-Hsiang Chan - West Windsor NJ, US
Nasrin Ansari - Monmouth Junction NJ, US
Michelle Lee Morris - Lawrenceville NJ, US
Yajing Rong - Dayton NJ, US
Michael Ohlmeyer - Plainsboro NJ, US
Andrew John Cooke - Newhouse, GB
Andrew Stanley Edwards - Newhouse, GB
David Jonathan Bennett - Newhouse, GB
Assignee:

MSD OSS B.V. - Oss
Pharmacopeia, Inc. - Cranbury NJ
International Classification:

A01N 43/62
A01N 43/58
A01N 43/60
A61K 31/55
A61K 31/535
A61K 31/50
A61K 31/495
A61K 31/497
A61K 31/4965
C07D 243/00
C07D 487/22
C07D 491/00
C07D 498/00
C07D 243/08
C07D 413/00
C07D 239/02
C07D 241/36
C07D 271/00
C07D 487/00
C07D 495/00
C07D 497/00
C07D 513/00
C07D 417/00
C07D 419/00
C07D 241/02
C07D 403/00
C07D 411/00
C07D 295/00
US Classification:

514218, 5142315, 5142358, 514250, 51425211, 51425213, 51425301, 51425401, 51425405, 5142541, 514 2, 514 5411, 51425403, 51425501, 51425404, 540555, 540575, 544121, 544306, 544338, 544357, 544367, 544371, 544377, 544379, 544391, 544386
Abstract:

The present invention relates to N-benzyl,N′-arylcarbonylpiperazine derivatives having the general formula I.

Phosphorescent Materials
view source
US Patent:

8519384, Aug 27, 2013
Filed:

Sep 3, 2009
Appl. No.:

13/062141
Inventors:

Chuanjun Xia - Lawrenceville NJ, US
Bert Alleyne - Ewing NJ, US
Raymond C. Kwong - Plainsboro NJ, US
James Fiordeliso - Morrisville PA, US
Jason Brooks - Philadelphia PA, US
Vadim Adamovich - Yardley PA, US
Michael S. Weaver - Princeton NJ, US
Nasrin Ansari - Monmouth NJ, US
Alan Deangelis - Pennington NJ, US
Dinesh Rayabarapu - Waldwick NJ, US
Assignee:

Universal Display Corporation - Ewing NJ
International Classification:

H01L 35/24
US Classification:

257 40, 257E51001
Abstract:

Novel organic compounds containing a twisted aryl group are provided. In particular, the compounds provided contain a 2-phenylpyridine ligand having a twisted aryl group on the pyridine portion of the ligand. The compounds may be used in organic light emitting devices, particularly as emitting dopants. Devices comprising the compounds containing twisted aryl may demonstrate improved color, efficiency, stability and manufacturing. Additionally, methods are provided for making homoleptic Ir (III) compounds which may contain a twisted aryl.

Phosphorescent Materials
view source
US Patent:

20110215710, Sep 8, 2011
Filed:

Aug 25, 2010
Appl. No.:

12/868350
Inventors:

Chuanjun Xia - Lawrenceville NJ, US
Bert Alleyne - Ewing NJ, US
Nasrin Ansari - Monmouth NJ, US
Assignee:

Universal Display Corporation - Ewing NJ
International Classification:

H01J 1/63
C07F 15/00
US Classification:

313504, 546 4, 544225, 544181
Abstract:

Compounds comprising a 2-phenylpyridine ligand further substituted with a heterocyclic group are provided. In particular, the compound comprises a 2-phenylpyridine ligand further substituted with a nitrogen-containing heterocycle. The compounds may be used in organic light emitting devices to provide devices having improved efficiency and lifetime.

1-(4-Ureidobenzoyl)Piperazine Derivatives
view source
US Patent:

20120015958, Jan 19, 2012
Filed:

Aug 26, 2009
Appl. No.:

13/060730
Inventors:

Andrew John Cooke - East Kilbride, GB
David Jonathan Bennett - Scotland, GB
Andrew Stanley Edwards - Glasgow, GB
Andrew Laird Roughton - Port Hope, CA
Irina Neagu - Belmont MA, US
Jui-Hsiang Chan - West Windsor NJ, US
Koc Kan Ho - West Windsor NJ, US
Nasrin Ansari - Monmouth Junction NJ, US
Michelle Lee Morris - Lawrenceville NJ, US
Yajing Rong - Yardley PA, US
Michael Ohlmeyer - Plainsboro NJ, US
International Classification:

A61K 31/496
C07D 417/06
C07D 405/06
C07D 409/06
C07D 403/06
A61P 3/04
A61P 9/10
A61P 7/00
A61P 1/00
A61P 3/06
A61P 3/10
C07D 413/06
C07D 401/06
US Classification:

51425313, 544369, 544379, 544371, 544365, 51425402, 5142541, 51425213, 51425405
Abstract:

The present invention relates to 1-(4-ureidobenzoyl)piperazine derivatives having the general Formula I (We bring to your attention that formula I is not provided on this electronic version as it is provided in the abstract of the paper copy) Wherein Ris (C)alkyl, (C)cycloalkyl or (C)cycloalkyl(C)alkyl, each of which may be substituted by hydroxy, cyano or halogen; Rrepresents 1 or 2 optional halogens; Ris (C)alkyl, (C)cycloalkyl or (C)cycloalkyl(C)alkyl, each of which may be substituted by one or more halogens; A represents a heteroaryl ring system comprising 1-3 heteroatoms selected from N, O and S, which ring system is 5- or 6-membered when X is C, and 5-membered when X is N; n is 1 or 2; or a pharmaceutically acceptable salt thereof; to pharmaceutical compositions comprising the same, and to the use of a these 1-(4-ureidobenzoyl)piperazine derivatives for the manufacture of a medicament for treating or preventing atherosclerosis and related disorders associated with cholesterol and bile acids transport and metabolism.

Phosphorescent Heteroleptic Phenylbenzimidazole Dopants
view source
US Patent:

20120292600, Nov 22, 2012
Filed:

May 19, 2011
Appl. No.:

13/111490
Inventors:

Gregg Kottas - Ewing NJ, US
Chuanjun Xia - Lawrenceville NJ, US
Zeinab Elshenawy - Holland PA, US
Nasrin Ansari - Monmouth Junction NJ, US
Assignee:

Universal Display Corporation - Ewing NJ
International Classification:

H01L 51/54
C07F 15/00
US Classification:

257 40, 546 4, 257E51024
Abstract:

Novel phosphorescent heteroleptic iridium complexes with benzimidazole and phenylpyridine ligands are provided. These iridium complexes can improve OLED properties, and are useful in white light applications.

Phosphorescent Heteroleptic Phenylbenzimidazole Dopants And New Synthetic Methodology
view source
US Patent:

20120292601, Nov 22, 2012
Filed:

May 19, 2011
Appl. No.:

13/111555
Inventors:

Gregg Kottas - Ewing NJ, US
Chuanjun Xia - Lawrenceville NJ, US
Nasrin Ansari - Monmouth Junction NJ, US
Assignee:

Universal Display Corporation - Ewing NJ
International Classification:

H01L 51/52
C07D 235/18
C07F 15/00
US Classification:

257 40, 546 4, 5483107, 257E51018
Abstract:

Novel heteroleptic iridium complexes are provided. These iridium complexes are useful compounds in OLED devices. The ligands for these novel complexes may be obtained using a new synthetic methodology that utilizes manganese dioxide.